FDA — authorised 27 April 2017
- Marketing authorisation holder: BIOMARIN PHARM
- Status: approved
🇺🇸 Rhttp1 in United States
FDA authorised Rhttp1 on 27 April 2017
Marketing authorisation
Rhttp1 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Rhttp1 approved in United States?
Yes. FDA authorised it on 27 April 2017.
Who is the marketing authorisation holder for Rhttp1 in United States?
BIOMARIN PHARM holds the US marketing authorisation.